NIAID Funding News, April 17, 2024

April 17, 2024 NIAID Funding News Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-04-17  Feature Article  FORMS-I Transition: Setting Up Dominoes to Topple on January 25, 2025 NIH will transition to FORMS-I for application due dates on or after January 25, 2025, and also implement new policies and procedures that accompany the switch. Opportunities and Resources Apply to Develop Clinical Research Platforms to Tailor HIV Curative Strategies Build a practical clinical research platform for rapidly and efficiently profiling participants' intact, rebound-competent HIV reservoirs and their immunologic profiles. Explore Opportunities to Join Emerging Infectious Diseases Network The Centers for Research in Emerging Infectious Diseases Network works to expand knowledge of re-emerging and emerging infectious diseases around the globe. Request Support to Study Inborn Errors of Immunity Research the causes and mechanisms of inborn errors of immunity, enable early detection and molecular diagnosis, and support strategies to treat and cure these disorders. Funding to Evaluate Novel Diagnostics for Tuberculosis in Endemic Countries Propose a partnership of investigators and existing clinical study sites in tuberculosis (TB) endemic countries, to evaluate early-stage TB diagnostic tests, assays, and strategies. New Initiative Highlights Women's Health Research Priorities Apply to conduct research on disease and health conditions that predominantly affect women, present and progress differently in women, or are female-specific. In The News Consider a Conceptual Approach to the NIH Budget and Success Rates The volume of awards that NIH is already obligated to fund each year can amplify, limit, or delay changes in success rates following a change in the overall budget. News Briefs and Worth Repeating Parent R01, R03, R21 NOFOs Will Now Expire in January 2025 Consider a New Perspective on Writing with Narrative Structure for Grant Applications Remember May 27 Deadline for Input on NIAID's Next Strategic Plan Advice Corner Acknowledge NIH Support Appropriately in Research Products NIH staff use award citations to evaluate the impact of grant funding on scientific progress over time. Similarly, peer reviewers rely on award citations to help assess award productivity. Reader Questions "May I request that my grant award be assigned to a particular program officer?" "Can I apply for an R01 grant with a 2- or 3-year project period?" New Funding Opportunities PAR-24-174, Global Infectious Disease Research Training Program (D43, Clinical Trial Optional) PA-24-185, Mentored Patient-Oriented Research Career Development Award (Parent K23, Independent Clinical Trial Not Allowed) RFA-AI-24-013, Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01, Clinical Trial Not Allowed) NOT-AI-24-012, Notice of Special Interest (NOSI): Competitive Revision Supplements to Existing T32 Programs to Include Institutional Research Training in Data Science for Infectious and Immune Mediated Diseases NOT-AI-24-031, Notice of Special Interest (NOSI): Resource-Related Research Project (R24) Applications to Support Collaborative Implementation Science to End the HIV Epidemic Find other announcements at NIAID Opportunities and Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107